drugset / Trial / NCT00091507

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

NCT00091507

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to test the impact of pharmacological myocardial metabolic support, in the form of intravenous (IV) glucose, insulin and potassium (GIK), for the treatment of patients with threatened or established acute myocardial infarction (AMI).

Timeline

Start
2006-11
Primary completion
2011-08
Completion
2012-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 30 % Intravenous
Subject Insulin Protein / enzyme biologic 50 iu Intravenous
Subject Potassium Chloride Small molecule 80 meq Intravenous